Turning Science into Consumer Brands
Acquisition, through purchase or licence of under-exploited healthcare products.
Our strategy is to acquire, through purchase or licence, products with proven innovative and relevant claims that have yet to be developed to their commercial potential. These could be, for example:
- Products with successful clinical trials and ideally registrations, that have yet to be introduced into the OTC market.
- Brands that have been successfully launched in one market but whose owners lack the resources and/or experience to develop them internationally.
- Products or brands which, in spite of having a differentiated claim within a specific category, fall outside the corporate strategic agenda of their current owners.